Nurse practitioners working in the oncology setting play an essential role in the management and education of patients receiving these therapies. This article provides a practical overview of anti-CD38 antibodies for oncology nurse practitioners, including infusion reaction mitigation, laboratory interpretation, and clinical decision making.

Reference: Verina D, Fowler A, Louw K, et al. CD38 Monoclonal Antibodies in Relapsed/Refractory Multiple Myeloma. The Journal for Nurse Practitioners. Volume 18, Issue 7, July–August 2022, Pages 693-698